BUCK; Elizabeth A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BUCK; Elizabeth A..The latest application filed is for "method of use for inhibitors of epidermal growth factor receptor variant iii".

Company Profile

0.6.17

BUCK; Elizabeth A. - Stony Brook NY
Buck; Elizabeth A. - Huntington NY US
Buck; Elizabeth A. - Farmingdale NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of Use for Inhibitors of Epidermal Growth Factor Receptor Variant III App 20180271853 - BUCK; Elizabeth A. ; et al.	2018-09-27
The Method of Use for Inhibitors of Epidermal Growth Factor Receptor Variants II, III and VI App 20180117053 - BUCK; Elizabeth A. ; et al.	2018-05-03
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors Grant 8,586,546 - Buck , et al. November 19, 2	2013-11-19
Combination Anti-cancer Therapy App 20130005733 - Barr; Sharon ; et al.	2013-01-03
Biological Markers Predictive Of Anti-cancer Response To Insulin-like Growth Factor-1 Receptor Kinase Inhibitors In Hepatocellular Carcinoma App 20120214830 - Buck; Elizabeth A. ; et al.	2012-08-23
Combined Treatment with an EGFR Kinase Inhibitor and an Agent that Sensitizes Tumor Cells to the Effects of EGFR Kinase Inhibitors App 20120207767 - Buck; Elizabeth A. ; et al.	2012-08-16
Combination Anti-cancer Therapy App 20120189641 - Buck; Elizabeth A. ; et al.	2012-07-26
Biological Markers Predictive of Anti-Cancer Response to Insulin-Like Growth Factor-1 Receptor Kinase Inhibitors App 20120101084 - Haley; John D. ; et al.	2012-04-26
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors Grant 8,114,846 - Buck , et al. February 14, 2	2012-02-14
Biological Markers Predictive Of Anti-cancer Response To Insulin-like Growth Factor-1 Receptor Kinase Inhibitors App 20110275644 - Buck; Elizabeth A. ; et al.	2011-11-10
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors Grant 8,048,621 - Haley , et al. November 1, 2	2011-11-01
Biological Markers Predictive Of Anti-cancer Response To Insulin-like Growth Factor-1 Receptor Kinase Inhibitors App 20110217309 - Buck; Elizabeth A. ; et al.	2011-09-08
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors Grant 7,939,272 - Buck May 10, 2	2011-05-10
Adrenocortical Carcinoma Treatment App 20100286155 - BUCK; Elizabeth A. ; et al.	2010-11-11
Combined Treatment With An Egfr Kinase Inhibitor And An Agent That Sensitizes Tumor Cells To The Effects Of Egfr Kinase Inhibitors App 20100166776 - Buck; Elizabeth A. ; et al.	2010-07-01
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors Grant 7,651,687 - Buck , et al. January 26, 2	2010-01-26
Combination anti-cancer therapy App 20090274698 - Bhagwat; Shripad ; et al.	2009-11-05
Combination anti-cancer therapy App 20090263397 - Buck; Elizabeth A. ; et al.	2009-10-22
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors App 20090093488 - Buck; Elizabeth A.	2009-04-09
Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors App 20090092596 - Haley; John D. ; et al.	2009-04-09
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors App 20070286864 - Buck; Elizabeth A. ; et al.	2007-12-13
Combined treatment with an EGFR kinase inhibitor and an agent that sensitizes tumor cells to the effects of EGFR kinase inhibitors App 20070280928 - Buck; Elizabeth A. ; et al.	2007-12-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.